GnTIII expression in plants

Details GnTIII expression in plants GnTIII expression in plants

2011-03-01

2011-03-01

Worley, Cathy Kingdon (Department: 1638)

Multicellular living organisms and unmodified parts thereof and

Plant, seedling, plant seed, or plant part, per se

Higher plant, seedling, plant seed, or plant part

C800S295000, C800S288000, C435S419000, C435S468000

Reexamination Certificate

active

07897842

ABSTRACT:
The invention relates to the field of glycoprotein processing in transgenic plants used as cost efficient and contamination safe factories for the production of recombinant biopharmaceutical proteins or pharmaceutical compositions comprising these glycoproteins. The invention provides a plant comprising a functional mammalian enzyme providing mammalian GnTIII that is normally not present in plants, said plant additionally comprising at least a second mammalian protein or functional fragment thereof that is normally not present in plants.

REFERENCES:
patent: 4956282 (1990-09-01), Goodman et al.
patent: 5202422 (1993-04-01), Hiatt et al.
patent: 5874271 (1999-02-01), Nishikawa et al.
patent: 5879912 (1999-03-01), Roth
patent: 5939288 (1999-08-01), Thornburg
patent: 5959177 (1999-09-01), Hein et al.
patent: 6046040 (2000-04-01), Nishiguchi et al.
patent: 6054304 (2000-04-01), Taniguchi et al.
patent: 6331418 (2001-12-01), Roth
patent: 6388068 (2002-05-01), Satoh et al.
patent: 6602684 (2003-08-01), Umana et al.
patent: 6653459 (2003-11-01), Schaewn
patent: 6998267 (2006-02-01), Seki et al.
patent: 2001/0055584 (2001-12-01), McKenzie et al.
patent: 2002/0174453 (2002-11-01), Danielle et al.
patent: 2004/0072290 (2004-04-01), Umana et al.
patent: 2004/0181827 (2004-09-01), Schaewn
patent: 2004/0214273 (2004-10-01), Fujiyama et al.
patent: 2005/0143564 (2005-06-01), Seki et al.
patent: 2005/0144670 (2005-06-01), Fujiyama et al.
patent: 2005/0223430 (2005-10-01), Bakker et al.
patent: 2006/0253928 (2006-11-01), Bakker et al.
patent: 2007/0089201 (2007-04-01), Briggs et al.
patent: 16813/00 (2000-06-01), None
patent: 19754622 (1999-06-01), None
patent: 0 351 313 (1990-01-01), None
patent: 0 550 756 (1993-07-01), None
patent: 0 737 745 (1996-10-01), None
patent: 1243647 (2002-09-01), None
patent: 2000/287692 (2000-03-01), None
patent: 2000-245470 (2000-09-01), None
patent: WO 92/18537 (1992-10-01), None
patent: 94 12646 (1994-06-01), None
patent: 95 02683 (1995-01-01), None
patent: 97 04122 (1997-02-01), None
patent: 98 31826 (1998-07-01), None
patent: WO 9831828 (1998-07-01), None
patent: WO 9924584 (1999-05-01), None
patent: WO 9929879 (1999-06-01), None
patent: 99 38987 (1999-08-01), None
patent: WO 99/38990 (1999-08-01), None
patent: 99 51185 (1999-10-01), None
patent: 00 29603 (2000-05-01), None
patent: WO 0028792 (2000-05-01), None
patent: 00 34490 (2000-06-01), None
patent: WO 00/34490 (2000-06-01), None
patent: WO 0049153 (2000-08-01), None
patent: WO 0052136 (2000-09-01), None
patent: 01 29242 (2001-04-01), None
patent: WO 01/29242 (2001-04-01), None
patent: 01 31044 (2001-05-01), None
patent: 01 31045 (2001-05-01), None
patent: WO 0149821 (2001-07-01), None
patent: WO 0149831 (2001-07-01), None
patent: WO 0162912 (2001-08-01), None
patent: WO 0164901 (2001-09-01), None
patent: 01 81591 (2001-11-01), None
patent: WO 0182912 (2001-11-01), None
patent: 02 00879 (2002-01-01), None
patent: 02 057468 (2002-07-01), None
patent: 02 070672 (2002-09-01), None
patent: 02 070672 (2002-09-01), None
patent: 03 011878 (2003-02-01), None
patent: 03 011878 (2003-02-01), None
patent: 03 078614 (2003-09-01), None
patent: 03 078614 (2003-09-01), None
patent: WO 03/078637 (2003-09-01), None
patent: WO 03076614 (2003-09-01), None
patent: WO 2004/050838 (2004-06-01), None
Bailey et al. Metabolic engineering of N-linked glycoform synthesis systems in Chinese hamster ovary (CHO) cells. (1997) Animal Cell Technology, pp. 489-494.
Chrispeels et al. The production of recombinant glycoproteins with defined non-immunogenic glycans. (1996) in Owen MRL, Pen J. (eds) Transgenic plants: a production system for industrial and pharmaceutical proteins. John Wiley Pub. UK, pp. 99-113.
Umana et al. Engineered glycoforms of an antineuroblastoma IgG1 with optimize antibody-dependent cellular cytotoxic activity. (1999)Nature Biotech. vol. 17, pp. 176-180.
Fischer et al. Molecular farming of recombinant antibodies in plants. (1999) Biol. Chem. vol. 380, pp. 825-839.
Wee et al. Targeting of active sialyltransferase to the plant golgi apparaatus. (1998) The Plant Cell; vol. 10; pp. 1759-1768.
Lerouge et al. N-glycosylation of recombinant pharmaceutical glycoproteins produced in transgenic plants: towards an humaization of plant N-glycans. (2000) Current Pharm. Biotech.; vol. 1; pp. 347-354.
Palacpac et al. Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. (1999) PNAS; vol. 96; pp. 4692-4697.
Bakker H et al: “Galactose-Extended Glycans of Antibodies Produced by Transgenic Plants”, Proceedings of the National Academy of Sciences of USA, National Academy of Science. Washington, US, vol. 98, No. 5, Feb. 27, 2001, pp. 2899-2904.
Bakker Hans et al: “An Arabidopsis Thaliana cDNA Complements The N-Acetylglucosaminyltransferase I Deficiency of CHO Lec1 Cells”, Biochemical and Biophysical Research Communications, vol. 261, No. 3, Aug. 11, 1999, pp. 829-832.
Cabanes-Macheteau Marion el al: “N-Glycosylation of a Mouse IgG Expressed in Transgenic Tobacco Plants.” Glycobioloby, vol. 9, No. 4, Apr. 1999, pp. 365-372.
Choi, Byung-Kwon et al.: Use of Combinatorial Genetic Libraries to Humanize N-Linked Glycosylation in the Yeast Pichia Pastoris, Apr. 29, 2003, Pnas vol. 100, No. 9, pp. 5022-5027.
Database EMBL 'Online! Apr. 28, 2000 Retrieved From Ebi Database Accession No. Aj 277603, Sequence, Annotation, Bakker, H “Arabidopsis Thaliana mRNA for Beta1,2-Xylosylftransferase (xylt gene)”.
Dinter A. et al: “The Regulation of Cell- and—Tissue-Sspecific Expression of Glycans by Glycosyltransferases”, Bioimmunology, Plenum Press, NY, 1995, pp. 53-82.
Elbers Ingrid J W et al: “Influence of Growth Conditions and Developmental Stage On N-Glycan Heterogeneity of Transgenic Immunoglobulin G and Endogenous Proteins in Tobacco Leaves”, Plant Physiology (Rockville), vol. 126, No. 3, Jul. 2001, pp. 1314-1322.
Essl D et al: “The N-Terminal 77 Amino Acids From Tobacco N-Acetylglucosaminyltransferase I Are Sufficient to Retain A Reporter Protein in The Golgi Apparatus of Nicotiana Benthamiana Cells” Febs Letters, Elsevier Science Publishers, Amsterdam, NI, vol. 453, No. 1-2, Jun. 18, 1999, pp. 169-173.
Fujiyama Kazuhito et al: “In Vivo Conversion of Glycan to Human Compatible Type by Transformed Tobacco Cells.” Biochemical and Biophysical Research Communications, vol. 289, No. 2, Nov. 30, 2001, pp. 553-557.
Gomez L and Chrispeels M J: “Complementation of An Arabidopsis Thaliana Mutant That Lacks Complex Asparagine-Linked Gylcans With the Human cDNA Encoding N-acetylglucosaminyltransferase I”, Proceedings of The National Academy of Sciences of USA, National Academy of Science. Washington, US, vol. 91, Mar. 1994, pp. 1829-1833.
Grabenhorst Eckart et al “The Cytoplasmic, Transmembrane, and Stem Regions of Glycosyltransferases Specify Their in Vivo Functional Sublocalization and Stability in the Golgi”, Journal of Biological Chemistry, vol. 274. No. 51, Dec. 17, 1999, pp. 36107-36116.
Hamilton, Stephen R. et al, Production of Complex Human Glycoproteins in Yeast, Aug. 29, 2003, Science, vol. 301, pp. 1244-1246.
Hollister, Jason et al, “Engineering The Protein N-Glycosylation Pathway in Insect Cells for Production of Biantennary Complex N-Glycans.”, Biochemistry, vol. 41, No. 50, Dec. 17, 2002, pp. 15093-15104.
Ihara Y et al: “cDNA Cloning, Expression, and Chromosomal Localization of Human N-acetylglucosaminyltransferase III (GnT-III)” Journal of Biochemistry, vol. 113, No. 6, 1993, pp. 692-698.
Jenkins N. et al: “Getting the Glycosylation Right: Implications for the Biotechnology Industry”, Nat Biobechnol Aug. 14, 1996: 14(8):975-81.
Kawar Ziad et al: “Insect Cells Encode a Class II Alpha-Mannosidase With Unique Properties”, Journal of Biological Chemistry, vol. 267, No. 19, May 11, 2001, pp. 16335-16340.
Kleene R et al: “Expression of Soluble Active Human Bete1, 4 Galactosyltransferase

Affiliated with

Also associated with

Rating

GnTIII expression in plants does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with GnTIII expression in plants, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GnTIII expression in plants will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2713706